Recent

% | $
Quotes you view appear here for quick access.

Zalicus AŞ Message Board

  • biotuesday biotuesday May 21, 2013 8:29 AM Flag

    Zalicus this week's BioTuesdays feature

    May 21, 2013 by leonardzehr · Leave a Comment

    Zalicus (NASADQ:ZLCS) will have data in the second half of this year that will provide important insights into the potential of its lead drug candidate, Z160, to be a breakthrough new class of non-opioid analgesic for the treatment of both chronic and acute neuropathic pain.

    “There hasn’t been a lot of innovation in the pain space in many years, and we are one of the few companies exploring multiple novel mechanisms to address pain,” Justin Renz, EVP and CFO, says in an interview with BioTuesday. “We have an opportunity for a breakthrough pain medication.” .........

    See BT for rest of article

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ZLCS
0.00(0.00%)